Last reviewed · How we verify

NCT06665685

BioButton Among Nursing Home Residents

Terminated NA Last updated 12 January 2026
What this trial tests

NA trial testing BioButton Device in Gait in 17 participants. Terminated before completion.

Timeline
11 March 2025
Primary endpoint
18 July 2025
18 July 2025

Quick facts

Lead sponsorCharles Lin
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment17
Start date11 March 2025
Primary completion18 July 2025
Estimated completion18 July 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Charles Lin

Who can join

18 and older, any sex, with Gait or Medication Induced Gait Disturbances. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This pilot study will explore the use of the BioIntellisense BioButton, a remote wearable multi-parameter monitor, to identify gait disturbances that occur as a side effect of polypharmacy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Gait

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06665685.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing